The impact of hyperthyroidism induced by Graves’ disease (GD) on skin microcirculation has not been established. We aimed to assess vascular reactivity in hyperthyroid GD patients before and during treatment.
METHODS:
Laser Doppler flux (LDF) was measured in 31 newly diagnosed hyperthyroid GD patients with an increased TSH receptor stimulating antibody (TSAb) levels before the methimazole treatment; and again 5.8 ± 0.8 months later when euthyroidism had been established; and in 30 healthy age- and gender-matched controls. Postocclusive reactive hyperaemia (PRH) was assessed by a 3-min occlusion of the brachial artery.
RESULTS:
Baseline LDF on the finger pulp and on the volar forearm were significantly higher in untreated GD patients compared to treated GD patients and controls (p < 0.05 for both). On the finger pulp, the time to maximal LDF during PRH was significantly shorter in untreated GD patients compared to controls (p < 0.05). On the forearm, the duration of PRH was significantly longer in untreated GD patients compared to controls (p < 0.05). Positive correlations of triiodothyronine and TSAb with some indices of PRH were established in treated GD patients.
CONCLUSIONS:
Hyperthyroidism induced by GD reversibly affects skin microcirculation, presumably by increasing the vasodilator capacity. Potential involvement of TSAb might be implicated.
AlhejilyW., AleksiA., MartinB.J. and AndersonT.J., The effect of ischemia-reperfusion injury on measures of vascular function, Clin Hemorheol Microcirc56 (2014), 265–271.
2.
BogazziF., BartalenaL., BrogioniS., BurelliA., ManettiL., TandaM.L., GasperiM. and MartinoE., Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: Studies in vivo by color flow doppler sonography, Eur J Endocrinol140 (1999), 452–456.
3.
BravermanI.M., The cutaneous microcirculation: Ultrastructure and microanatomical organization, Microcirculation4 (1997), 329–340.
4.
BüssemakerE., PoppR., FisslthalerB., LarsonC.M., FlemingI., BusseR. and BrandesR.P., Hyperthyroidism enhances endothelium-dependent relaxation in the rat renal artery, Cardiovasc Res59 (2003), 181–188.
5.
Carrillo-SepúlvedaM.A., CeravoloG.S., FortesZ.B., CarvalhoM.H., TostesR.C., LaurindoF.R., WebbR.C. and Barreto-ChavesM.L., Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes, Cardiovasc Res85 (2010), 560–570.
6.
CikimA.S., OflazH., OzbeyN., CikimK., UmmanS., MericM., SencerE. and MolvalilarS., Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism, Thyroid14 (2004), 605–609.
7.
DagreA.G., LekakisJ.P., ProtogerouA.D., DouridasG.N., PapaioannouT.G., TryfonopoulosD.J., PapamichaelC.M. and AlevizakiaM., Abnormal endothelial functions in female patients with hypothyroidism and borderline thyroid function, Int J Cardiol114 (2007), 332–338.
8.
DardanoA., GhiadoniL., PlantingaY., CaraccioN., BemiA., DurantiE., TaddeiS., FerranniniE., SalvettiA. and MonzaniF., Recombinant human TSH reduces endothelium dependent vasodilation in patients monitored for differentiated thyroid carcinoma, J Clin Endocrinol Metab91 (2006), 4175–4178.
9.
DonniniD., Ambesi-ImpiombatoF.S. and CurcioF., Thyrotropin stimulates production of procoagulant and vasodilatative factors in human aortic endothelial cells, Thyroid13 (2003), 517–521.
10.
GiustiM., ValentiS., GuazziniS.B., MolinariE., CavalleroD., AugeriC. and MinutoF., Circulating nitric oxide is modulated by recombinant human TSH administration during monitoring of thyroid cancer remnant, J Endocrinol Invest26 (2003), 1192–1197.
11.
HánaV., Prázn’yM., MarekJ., SkrhaJ. and JustováV., Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement, Eur J Endocrinol147 (2002), 333–337.
12.
HolowatzL.A., Thompson-TorgersonC.S. and KenneyW.L., The human cutaneous circulation as a model of generalized microvascular function, J Appl Physiol105(1) (2008), 370–372.
13.
JohnsonJ.M. and KelloggD.L.Jr, Thermoregulatory and thermal control in the human cutaneous circulation, Frontiers BiosciS2 (2010), 825–853.
14.
JungF., LeithäuserB., LandgrafH., JüngerM., FranzeckU., PriesA., SternitzkyR., FrankeR.P., ForconiS. and EhrlyA.M., Laser doppler flux measurement for the assessment of cutaneous microcirculation - critical remarks, Clin Hemorheol Microcirc55 (2013), 411–416.
15.
KleinI. and OjamaaK., Thyroid hormone: Targeting the vascular smooth muscle cell, Circ Res88 (2001), 260–261.
16.
KleinI. and DanziS., Thyroid disease and the heart, Circulation116 (2007), 1725–1735.
17.
LekakisJ., PapamichaelC., AlevizakiM., PiperingosG., MarafeliaP., MantzosJ., StamatelopoulosS. and KoutrasD.A., Flow-mediated, endothelium dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values, Thyroid7 (1997), 411–414.
18.
LenasiH. and StruclM., Regular physical activity alters the postocclusive reactive hyperemia of the cutaneous microcirculation, Clin Hemorheol Microcirc45 (2010), 365–374.
19.
LenasiH., Assessment of human skin microcirculation and its endothelial function using laser Doppler flowmetry, In: Medical imaging, EronduO.F., ed, InTech, Rijeka, 2011. pp. 271–296
20.
MazzaA., BeltramelloG., ArmigliatoM., MontemurroD., ZorzanS., ZuinM., RampinL., MarzolaM.C., GrassettoG., Al-NahhasA. and RubelloD., Arterial hypertension and thyroid disorders: What is important to know in clinical practice?Ann Endocrinol72 (2011), 296–303.
21.
MedowM.S., TanejaI. and StewartJ.M., Cyclooxygenase and nitric oxide synthase dependence of cutaneous reactive hyperemia in humans, Am J Physiol Heart Circ Physiol239 (2007), H425–H432.
22.
MilgromE., de RouxN., GhineaN., BeauI., LoosfeltH., VannierB., SavouretJ.F. and MisrahiM., Gonadotropin and thyrotropin receptors, Horm Res48 (1997), 33–37.
23.
MorenoJ.M., WangensteenR., SainzJ., Rodríguez-GomezI., ChamorroV., OsunaA., VargasF., Role of endothelium-derived relaxing factors in the renal response to vasoactive agents in hypothyroid rats, Am J Physiol Endoc M285 (2003), E182–E188.
24.
MurisD.M., HoubenA.J., KroonA.A., HenryR.M., van der KallenC.J., SepS.J., KosterA., DagnelieP.C., SchramM.T. and StehouwerC.D., Age, waist circumference, and blood pressure are associated with skin microvascular flow motion: The Maastricht Study, J Hypertens (2014) [Epub ahead of print].
25.
NapoliR., BiondiB., GuardasoleV., MatarazzoM., PardoF., AngeliniV., FazioS. and SaccáL., Impact of hyperthyroidism and its correction on vascular reactivity in humans, Circulation104 (2001), 3076–3080.
26.
NapoliR., GuardasoleV., AngeliniV., ZarraE., TerraccianoD., D’AnnaC., MatarazzoM., OlivieroU., MacchiaV. and SaccaL., Acute effects of triiodothyronine on endothelial function in human subjects, J Clin Endocrinol Metabol92 (2007), 250–254.
27.
NapoliR., BiondiB., GuardasoleV., D’AnnaC., De SenaA., PirozziC., TerraccianoD., MazzarellaC., MatarazzoM. and SaccáL., Enhancement of vascular endothelial function by recombinant human thyrotropin, J Clin Endocrinol Metab93 (2008), 1959–1963.
28.
NapoliR., ApuzziV., BossoG., D’AnnaC., De SenaA., PirozziC., MaranoA., LupoliG.A., CudemoG., OlivieroU., MatarazzoM., LupoliG. and SaccáL., Recombinant human thyrotropin enhances endothelial-mediated vasodilation of conduit arteries, J Clin Endocrinol Metab94 (2009)(2009), 1012–1016.
29.
Pazos-MouraC.C., MouraE.G., BreitenbachM.M. and BouskelaE., Nailfold capillaroscopy in hypothyroidism and hyperthyroidism: Blood flow velocity during rest and postocclusive reactive hyperemia, Angiology49 (1998), 471–476.
30.
RapoportB. and McLachlanS.M., The thyrotropin receptor in Graves’ disease, Thyroid17 (2007), 911–922.
SellittiD.F., DennisonD., AkamizuT., DoiS.Q., KohnL.D. and KoshiyamaH., Thyrotropin regulation of cyclic adenosine monophosphate production in human coronary artery smooth muscle cells, Thyroid10 (2000), 219–225.
33.
SilvaJ.E., The Thermogenic Effect of Thyroid Hormone and Its Clinical Implications, Ann Intern Med139 (2003), 205–213.
34.
ShepherdA.P. and ObergP.A. eds., Laser-Doppler blood flowmetry, Kluwer Academic Publishers, Boston Dordrecht London, 1990.
35.
TonaccheraM., Van SandeJ., ParmaJ., DuprezL., CetaniF., CostagliolaS., DumontJ.E. and VassartG., TSH receptor and disease, Clin Endocrinol (Oxf)44 (1996), 621–633.
36.
VargasF., MorenoJ.M., Rodríguez-GómezI., WangensteenR., OsunaA., Alvarez-GuerraM. and García-EstañJ., Vascular and renal function in experimental thyroid disorders, Eur J Endocrinol154 (2006), 197–212.
37.
WeissM., MilmanB., RosenB. and ZimlichmanR., Quantitation of thyroid hormone effect on skin perfusion by laser Doppler flowmetry, J Clin Endocrinol Metabol76 (1993), 680–682.
38.
YenP.M., Physiological and molecular basis of thyroid hormone action, Physiol Rev81 (2001), 1097–1142.
